![A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4c56dec5-310c-4e24-ab78-fbf95f7c8023/gr1.jpg)
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
![Event‐free and overall survival for all study participants (A and B).... | Download Scientific Diagram Event‐free and overall survival for all study participants (A and B).... | Download Scientific Diagram](https://www.researchgate.net/publication/360690638/figure/fig2/AS:1161480774926336@1653930004214/Event-free-and-overall-survival-for-all-study-participants-A-and-B-Overall-survival.png)
Event‐free and overall survival for all study participants (A and B).... | Download Scientific Diagram
![Event Studies for Charter Entrance on Each Sub-category. Notes: Event... | Download Scientific Diagram Event Studies for Charter Entrance on Each Sub-category. Notes: Event... | Download Scientific Diagram](https://www.researchgate.net/publication/341093018/figure/fig2/AS:962152630333491@1606406471823/Event-Studies-for-Charter-Entrance-on-Each-Sub-category-Notes-Event-studies-show-trends.png)
Event Studies for Charter Entrance on Each Sub-category. Notes: Event... | Download Scientific Diagram
![Medical Science Monitor | Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis - Article abstract #934588 Medical Science Monitor | Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis - Article abstract #934588](https://jours.isi-science.com/imageXml.php?i=medscimonit-28-e934588-g001.jpg&idArt=934588&w=1000)
Medical Science Monitor | Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis - Article abstract #934588
![A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death - Kidney International A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fa5b5563-bbd5-4ff7-852f-b0bd5a8fd5ad/fx1_lrg.jpg)
A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death - Kidney International
![Adverse Events Among Emergency Department Patients With Cardiovascular Conditions: A Multicenter Study - Annals of Emergency Medicine Adverse Events Among Emergency Department Patients With Cardiovascular Conditions: A Multicenter Study - Annals of Emergency Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7cc74b12-83dc-4285-b219-54aca5507a36/gr1_lrg.jpg)
Adverse Events Among Emergency Department Patients With Cardiovascular Conditions: A Multicenter Study - Annals of Emergency Medicine
![Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data | Military Medical Research | Full Text Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data | Military Medical Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40779-021-00331-6/MediaObjects/40779_2021_331_Fig5_HTML.png)
Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data | Military Medical Research | Full Text
![Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study - European Journal of Cancer Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b98b535c-9b9a-45ed-bc17-fc425a85d6bb/gr1_lrg.jpg)
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study - European Journal of Cancer
![The Association of Potentially Inappropriate Medication at Older Age With Cardiovascular Events and Overall Mortality: A Systematic Review and Meta-Analysis of Cohort Studies - Journal of the American Medical Directors Association The Association of Potentially Inappropriate Medication at Older Age With Cardiovascular Events and Overall Mortality: A Systematic Review and Meta-Analysis of Cohort Studies - Journal of the American Medical Directors Association](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e9795e4d-11de-4052-a1f3-64d2655c7d19/gr1.jpg)
The Association of Potentially Inappropriate Medication at Older Age With Cardiovascular Events and Overall Mortality: A Systematic Review and Meta-Analysis of Cohort Studies - Journal of the American Medical Directors Association
![Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial - The Lancet Oncology Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/020bf613-ed77-440d-ac8a-684577237be4/gr1.gif)
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial - The Lancet Oncology
![PDF) Determinants of Convention & Conference Site Selection: The Polish Event Planners' Perspective (in English) | Magdalena Kachniewska - Academia.edu PDF) Determinants of Convention & Conference Site Selection: The Polish Event Planners' Perspective (in English) | Magdalena Kachniewska - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/36847166/mini_magick20180818-26501-2jsv4r.png?1534597366)
PDF) Determinants of Convention & Conference Site Selection: The Polish Event Planners' Perspective (in English) | Magdalena Kachniewska - Academia.edu
![Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non–small-cell Lung Cancer: A Retrospective Study - Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non–small-cell Lung Cancer: A Retrospective Study -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a9bd162e-4c6a-436e-bbf5-e3e3d4c8eca0/gr1.jpg)
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non–small-cell Lung Cancer: A Retrospective Study -
![Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis | Prostate Cancer and Prostatic Diseases Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41391-021-00395-4/MediaObjects/41391_2021_395_Fig1_HTML.png)